ICS 2022 (France) - P.Kory - «The War on Off-Patent Medicines in Covid-19. Battle of Ivermectin»

March 31, 2022 - ICS - Dr Pierre Kory - «The War on Off-Patent Medicines in Covid-19. The Battle of Ivermectin».

Dr. Pierre Kory is the former Chief of Critical Care and Medical Director of Trauma and Life Services at the University of Wisconsin. Dr. Kory led COVID-19 intensive care units throughout the pandemic and was the first to support the diagnosis of early COVID-19 respiratory disease as organized pneumonia, thus explaining the critical response of the disease to corticosteroids. As president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC), he has testified twice in the U.S. Senate regarding Covid-19.

The University Hospital Institute of Infectious Diseases of Marseille ( IHU Méditerranée Infection) hosted the "International Covid Summit" for two days, organized by the association RéInfoLiberté and the Syndicat Enseignement Recherche Liberté. Participants : Doctor Robert MALONE (USA), the inventor of the mRNA technology; Professor Jean-Paul BOURDINEAUD, biochemist and toxicologist; Doctor Claude ESCARGUEL, microbiologist; Professor Philippe COLSON, molecular biology; Doctor Pierre KORY (USA), specialized in intensive care ; Doctor Laurent TOUBIANA, epidemiologist and researcher at INSERM; Doctor Hélène BANOUN, pharmacist-biologist in charge of research at INSERM; Professor Peter A. McCULLOUGH (USA), cardiologist; Professor Harvey RISCH (USA), epidemiologist; Professor Stéphanie GENTILE, Professor of Medicine at AP-HM; Doctor Gérard MAUDRUX, surgeon-urologist; Doctor Pierre SONIGO, molecular biologist and virologist, director of research at INSERM; Doctor Vincent PAVAN, mathematician; Doctor Laurent MUCCHIELI, sociologist, director of research at CNRS.

The program for March 30 and 31: https://reinfoliberte.fr/wp-content/uploads/2022/03/Program-ICS-Marseille-2.pdf

The program for April 1 and 2: https://reinfoliberte.fr/wp-content/uploads/2022/04/Program-ICS-Massy-APRIL-1-2-20222.pdf

#ICS #ICS2022 #InternationalCovidSummit #IHU #COVID19 #reinfolberté #PierreKory #Ivermectine #Treatment